High dose Interleukin 2 (HD IL2) as 15t line treatment in metastatic renal cell carcinoma (mRCC): A 10-year single centre experience
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL ONCOLOGY ; MAY 20 2016, 34 15, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15277755